Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-25

Clinical Trial Update: An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension [Phase 3]

View source ↗

Summary

Phase 3 pediatric hypertension trial completed with efficacy and safety results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Arbor Pharmaceuticals, Inc. | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2025-02-25